This application for continuation of the Specialized Program of Research Excellence (SPORE) in Gastrointestinal Cancer at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins supports a highly interactive, multidisciplinary, and inter-institutional program. Five research projects within three research themes, four cores, a career development and a research developmental program are proposed to extend our translational research In colorectal and pancreatic cancer. Theme 1: Epidemiology and Inborn risk (Project 1, Markers for risk in familial pancreatic cancer, Drs. Klein, Hruban, and Goggins) Theme 2: Management of risk (Project 2, Markers for screening and diagnosis, Drs. Goggins and Kinzler;Project 3, Diagnostic strategies and risk-assessment for pancreatic cysts, Drs. Kinzler, Maitra, and Goggins). Theme 3: Post-diagnostic management (Project 4, Tumor antigens for individual signatures and therapy, Drs. Jaffee, Kern, and lacobuzio-Donahue;Project 5, Access of therapeutic agents to cancer cells, Drs. Zhou, Kern, and lacobuzio-Donahue). The cores support the research programs (Core 1, Administration and Communication, Dr. Scott Kern;Core 2, Human Tissue Research and Logistics, Dr. Christine lacobuzio-Donahue;Core 3, Familial Cancer Registries, Dr. Frank Giardiello;Core 4, Statistics/Bioinformatics, Drs. Alison Klein. The Career Development Program (Dr. Scott Kern) aids the emergence of new investigators and the Research Developmental Program (Dr. Bert Vogelstein) provides rapid funding of innovative directions.
This research program provides a spectrum of capabilities, allowing broad research moving from the lab bench to the patient for improved diagnosis and care, and studies of gastrointestinal cancers that move back to the lab for fundamental understanding of their scientific basis.
|Wood, Laura D; Noë, Michaël; Hackeng, Wenzel et al. (2017) Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas. Virchows Arch 470:391-400|
|Luchini, Claudio; Robertson, Scott A; Hong, Seung-Mo et al. (2017) PBRM1 loss is a late event during the development of cholangiocarcinoma. Histopathology 71:375-382|
|Murphy, Adrian G; Foley, Kelly; Rucki, Agnieszka A et al. (2017) Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. Oncotarget 8:106405-106414|
|Rucki, Agnieszka A; Foley, Kelly; Zhang, Pingbo et al. (2017) Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer. Cancer Res 77:41-52|
|Jinawath, Natini; Shiao, Meng-Shin; Norris, Alexis et al. (2017) Alterations of type II classical cadherin, cadherin-10 (CDH10), is associated with pancreatic ductal adenocarcinomas. Genes Chromosomes Cancer 56:427-435|
|Tsujikawa, Takahiro; Kumar, Sushil; Borkar, Rohan N et al. (2017) Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis. Cell Rep 19:203-217|
|Suenaga, Masaya; Sadakari, Yoshihiko; Almario, Jose Alejandro et al. (2017) Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video). Gastrointest Endosc 86:1152-1156.e2|
|Todoric, Jelena; Antonucci, Laura; Di Caro, Giuseppe et al. (2017) Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. Cancer Cell 32:824-839.e8|
|Mattox, Austin K; Wang, Yuxuan; Springer, Simeon et al. (2017) Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations. Proc Natl Acad Sci U S A 114:4733-4738|
|Johnson 3rd, Burles A; Yarchoan, Mark; Lee, Valerie et al. (2017) Strategies for Increasing Pancreatic Tumor Immunogenicity. Clin Cancer Res 23:1656-1669|
Showing the most recent 10 out of 843 publications